Clinical trial Recruiting at 1 site Interventional Ages 18 to 50

Focused LED red-light treatment for adults with nearsightedness

Official title: Safety and Efficacy of Focused LED-Based Repeated Low-Level Red-Light Therapy in Myopic Adults: A Single-Arm Pilot Study

Run by The Hong Kong Polytechnic University · NCT07369804 · Data updated 2026-11-12

This pilot tests whether short, home-based red LED light sessions can thicken the choroid and boost choroidal blood flow in adults ages 18–50 with mild to moderate myopia.

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexAll
Enrollment14 (estimated)
SponsorThe Hong Kong Polytechnic University
Academic / other
Locations1 site (Hong Kong, Hong Kong)
StatusRecruiting
StartedOctober 8, 2025
Main results expectedJuly 31, 2026
Study endsJuly 31, 2026
Registry record updatedJanuary 27, 2026
Trial IDNCT07369804 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18–50 years old with mild to moderate myopia (SE −0.50 to −6.00 D), astigmatism ≤1.50 D, best-corrected visual acuity better than 20/20, and no recent myopia-control treatments or ocular surgery.

Probably not a fit

Patients with high myopia beyond −6.00 D, significant ocular disease, prior ocular surgery, binocular vision disorders like strabismus, recent myopia-control interventions, or an afterimage time >5 minutes are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, single-arm, open-label pilot will enroll 14 myopic adults (18–50 years) with spherical equivalent refractions of −0.50 to −6.00 D to receive focused LED-based repeated low-level red-light (fLED-RLRL) therapy. Participants will use a home device (650 ± 10 nm, 0.20 mW) twice daily for 3 minutes per session, five days per week for 28 days while wearing single-vision spectacles. The primary outcomes are changes in choroidal thickness and choroidal blood flow, and secondary outcomes focus on safety and tolerability. Key exclusions include recent myopia-control treatments within 6 months, prior ocular surgery, strabismus, and other ocular or systemic abnormalities.

Why it matters

Potential benefit: If successful, the therapy could increase choroidal thickness and blood flow and potentially support a noninvasive home-based approach to reduce myopia-related eye changes.

How similar studies have gone: Similar low-level red-light protocols have produced short-term choroidal thickening and slowed progression in pediatric studies, but adult data are limited and this adult protocol is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 18-50 years.
2. SE refractions between -0.50 and -6.00 diopters (D)
3. Astigmatism of 1.50 D or less.
4. Best corrected monocular visual acuity better than 20/20 (Snellen equivalent).
5. Willingness to provide written informed consent and comply with the treatment protocol.

Exclusion Criteria:

1. Strabismus or binocular vision abnormalities in either eye.
2. Ocular abnormalities in either eye or other systemic abnormalities.
3. Previous or current use of myopia control interventions (e.g., orthokeratology, low-dose atropine, pirenzepine) within the past 6 months.
4. History of ocular surgeries (e.g., cataract surgery and LASIK/SMILE).
5. Afterimage time \> 5 minutes (contraindications to RLRL therapy).

Where it's running

  • The Hong Kong Polytechnic University
    Hong Kong, Hong Kong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.